Effects of tyrosine kinase inhibitor-masitinib mesylate on canine mammary tumour cell lines Cover

.blurhash-client-img { display: none !important; }

Effects of tyrosine kinase inhibitor-masitinib mesylate on canine mammary tumour cell lines

Journal of Veterinary Research

Volume 65 (2021): Issue 3 (September 2021)

By: Fulya Ustun-Alkan, Tülay Bakırel, Oya Üstüner, Ceren Anlas, Suzan Cinar, Funda Yıldırım and Aydın Gürel

Open Access

|Jul 2021

Authors

Fulya Ustun-Alkan

Department of Pharmacology and Toxicology, Istanbul, Turkey

Tülay Bakırel

Department of Pharmacology and Toxicology, Istanbul, Turkey

Oya Üstüner

Department of Pharmacology and Toxicology, Istanbul, Turkey

Ceren Anlas

Department of Pharmacology and Toxicology, Istanbul, Turkey

Suzan Cinar

Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey

Funda Yıldırım

Department of Pathology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey

Aydın Gürel

Department of Pathology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey

DOI: https://doi.org/10.2478/jvetres-2021-042 | Journal eISSN: 2450-8608

Journal RSS Feed

Language: English

Page range: 351 - 359

Submitted on: Feb 5, 2021

|

Accepted on: Jul 5, 2021

|

Published on: Jul 24, 2021

Published by: National Veterinary Research Institute in Pulawy

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

tyrosine kinase inhibitor,

canine mammary cancer,

Related subjects:

Molecular biology,

Microbiology and virology,

Life sciences, other,

Veterinary medicine

© 2021 Fulya Ustun-Alkan, Tülay Bakırel, Oya Üstüner, Ceren Anlas, Suzan Cinar, Funda Yıldırım, Aydın Gürel, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 65 (2021): Issue 3 (September 2021)Next article